BioPlasma Research Group, School of Food Science and Environmental Health, Technological University Dublin, Dublin, Ireland.
Environmental Sustainability & Health Institute (ESHI), Technological University Dublin, Dublin, Ireland.
PLoS One. 2022 Sep 22;17(9):e0274524. doi: 10.1371/journal.pone.0274524. eCollection 2022.
Since first identified in 1879, plasma, the fourth state of matter, has been developed and utilised in many fields. Nonthermal atmospheric plasma, also known as cold plasma, can be applied to liquids, where plasma reactive species such as reactive Oxygen and Nitrogen species and their effects can be retained and mediated through plasma-activated liquids (PAL). In the medical field, PAL is considered promising for wound treatment, sterilisation and cancer therapy due to its rich and relatively long-lived reactive species components. This study sought to identify any potential antagonistic effect between antioxidative intracellularly accumulated platinum nanoparticles (PtNPs) and PAL. We found that PAL can significantly reduce the viability of glioblastoma U-251MG cells. This did not involve measurable ROS influx but instead lead to lipid damage on the plasma membrane of cells exposed to PAL. Although the intracellular antioxidative PtNPs showed no protective effect against PAL, this study contributes to further understanding of principle cell killing routes of PAL and discovery of potential PAL-related therapy and methods to inhibit side effects.
自 1879 年首次被发现以来,等离子体——物质的第四种状态——已经在许多领域得到了发展和利用。非热常压等离子体,也称为冷等离子体,可以应用于液体中,其中等离子体活性物质(如活性氧和氮物种及其作用)可以通过等离子体激活液体(PAL)保留和介导。在医学领域,由于其丰富且相对持久的活性物质成分,PAL 被认为在伤口治疗、杀菌和癌症治疗方面有很大的应用前景。本研究旨在确定细胞内积累的抗氧化性铂纳米颗粒(PtNPs)与 PAL 之间是否存在潜在的拮抗作用。我们发现 PAL 可以显著降低神经胶质瘤 U-251MG 细胞的活力。这并不涉及可测量的 ROS 流入,而是导致暴露于 PAL 的细胞的质膜上的脂质损伤。尽管细胞内抗氧化性 PtNPs 对 PAL 没有保护作用,但本研究有助于进一步了解 PAL 的主要细胞杀伤途径,并发现潜在的与 PAL 相关的治疗和抑制副作用的方法。